Anterior Cervical Discectomy, Pain Management, Peripheral Nerve Block
Conditions
Keywords
Anterior Cervical Discectomy, Serratus Posterior Superior Intercostal Plane Block, Erector Spinae Plane Block
Brief summary
Anterior cervical discectomy is an operation performed for complaints of pain, numbness or loss of strength due to cervical disc disease. With this operation, pressure due to herniation on the upper neck area, spinal cord or nerve roots is relieved. It is performed by microscopic method from the front of the neck. Nerve blocks reduces opioid consumption in the postoperative period by providing better pain control and therefore has advantages such as fewer side effects and less risk of pulmonary and cardiac complications. In this study; it was aimed to compare the analgesic effectiveness of serratus posterior superior intercostal plane block and erector spinae plane block, with each other and with the control group in the postoperative period in patients who underwent anterior cervical discectomy.
Interventions
PROCEDURESerratus posterior superior intercostal plane block
Serratus posterior superior intercostal plane block will be performed on the patients using 30 ml of 0.25% bupivacaine under ultrasound guidance. Additionally, in the postoperative period a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.
PROCEDUREErector spinae plane block
Erector spinae plane block will be performed on the patients using 30 ml of 0.25% bupivacaine under ultrasound guidance. Additionally, in the postoperative period a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.
PROCEDUREGroup without peripheral nerve block
In the postoperative period a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.
Sponsors
Ankara Etlik City Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patients aged 18-80 years * American Society of Anesthesiologists (ASA) score I-II-III * Body Mass Index (BMI) between 18-30 kg/m2
Exclusion criteria
* Patients under 18 and over 80 years of age * ASA score IV and above * Patients with a history of bleeding diathesis * BMI below 18 or above 30 kg/m2
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain Scores | On the operation day | Pain will be assessed at rest and while coughing using the visual analog scale on a scale from 0 (no pain) to 10 (worst pain). Pain assessment will be done at 0st, 1st, 2nd,4th, 12th, and 24th hours after surgery. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Intraoperative remifentanil consumption Intraoperative opioid consumption | Intraoperative period | Remifentanil consumption for intraoperative period will be recorded |
| Postoperative Tramadol Consumption | On the operation day | Tramadol consumption for 24 hours will be recorded |
Countries
Turkey (Türkiye)
Contacts
Primary ContactAtakan Sezgi
Backup ContactMusa Zengin
Outcome results
None listed